United Therapeutics (NASDAQ:UTHR) Downgraded by StockNews.com

StockNews.com lowered shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Friday. Other equities research analysts also recently issued research reports about the stock. Wedbush restated an outperform rating and issued a $308.00 price target on shares of United Therapeutics […]

Related Keywords

United States , Paula Mahon , Leerink Partnrs , Martinea Rothblatt , Securities Exchange Commission , Goldman Sachs Group , Norges Bank , Dimensional Fund Advisors , Nasdaq , United Therapeutics Corporation , Vanguard Group Inc , United Therapeutics , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Fund Advisors , Therapeutics Corporation , United Therapeutics Daily ,